Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

The first-line treatment options for advanced and metastatic non-clear cell renal cell carcinoma (RCC) are growing, and various long-term updates on phase II trials were presented at the American ...

Chromophobe renal cell carcinoma is a rare subtype of kidney cancer. It begins in the cells that line the small tubes in the kidney that filter waste from the blood to make urine. A 2017 article ...

TOPLINE: Adjuvant everolimus does not improve recurrence-free or overall survival in patients with papillary and chromophobe subtypes of non–clear cell renal cell carcinoma (RCC) and is ...

Chromophobe RCC First described in 1985, chromophobe RCC accounts for approximately 5% of renal tumors.15 This RCC subtype has a better prognosis than either clear cell or papillary RCC, but it is ...

The lead singer of 3 Doors Down, Brad Arnold, is adamant it's not his time yet. The 46-year-old vocalist shared on the band's social media on Wednesday that he had "some not-so-good news for you today ...

In a recent study published in Cancers, researchers explored the association between the human microbiome and improved renal cell carcinoma (RCC) outcomes. Study: A New Treatment Landscape for RCC ...

According to the World Health Organization’s (WHO) 2022 classification of kidney tumors, health experts now refer to clear cell papillary renal cell carcinoma as CCPRCT.

These RCC patients consisted of two subtypes of renal cancer- clear cell and non-clear cell RCC which are known to respond differently to treatments. Xu et al. identified distinct patterns of tumor T ...

Researchers are exploring the use of circulating tumor (ct) DNA to guide treatment decisions and aid in clinical trial selection for patients with renal cell carcinoma (RCC). A recent study in ...

Renal cell carcinoma accounts for approximately nine out of 10 cases of kidney cancers. RCCs form as tumors, or masses of cancer cells, in the tubules within the kidney. These tubules are key to the ...

In one patient, total body scans were performed at 15 minutes, 1 hour, 2 hours, and 4 hours post-injection. The effective dose was 0.022 mSv/MBq, with the stomach wall receiving the highest organ dose ...